TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells.
about
Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell lineRole of TIM-3 in ovarian cancer.Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expressionGalectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Tim-3 and its role in regulating anti-tumor immunity.Tim-3 expression in cervical cancer promotes tumor metastasis.Tim-3 expression defines regulatory T cells in human tumors.Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaDecreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancerUp-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.Expression of Tim-3 in gastric cancer tissue and its relationship with prognosisCell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretionTim-3 enhances FcεRI-proximal signaling to modulate mast cell activation.T Cell Immunoglobulin Mucin Domain (TIM)-3 Promoter Activity in a Human Mast Cell Line.F-fucoidan from Saccharina japonica is a novel inducer of galectin-9 and exhibits anti-allergic activityTGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathwayAbnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients.TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens.Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.The role of TIM-containing molecules in airway disease and their potential as therapeutic targets.TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.Emerging immune checkpoints for cancer therapy.TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia/lymphoma.Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.Tim-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer DiseaseT-cell immunoglobulin mucin-3 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes.The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung.The increase of plasma galectin-9 in a patient with insulin allergy: a case reportThe Binding Properties of Glycosylated and Non-Glycosylated Tim-3 Molecules on CD4CD25 T Cells.Controversial role of mast cells in skin cancers.Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC.Immune regulation by Tim-3.TIM3 expression by leukemic and non-leukemic myeloblasts.Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.Tim-3 expression and its role in hepatocellular carcinoma
P2860
Q24323267-D1B7C43E-6B44-491A-9969-ECE2288FC633Q30235023-985B1AF8-C755-40F7-85CD-CD05C6A6DB66Q30432023-004C37F4-A4B7-4833-B730-5DB2ED4A0EF0Q33816240-80671DEC-7426-4344-92F9-F6A979FE86DBQ33828349-209E28CC-2B6B-4A93-9E0A-34BDCAE2C5D3Q33909020-7D6192AC-68F7-48DF-A38F-78A4A3EFEF0AQ34555771-545581AD-306D-4349-AC64-EA866E9A2068Q34634058-BF2F1BC4-43BD-471F-B484-57978B9AD002Q34997704-58BC6408-DAFC-4556-A9D4-677ADA932F08Q35067641-4810AB5A-990F-4FF9-BB48-96648A38337BQ36014245-6F665470-749B-4550-B322-8B895A3A69BCQ36095348-1BAF54D4-F1F8-4188-A2EA-60DE92833225Q36381148-5CC03FF4-DEC4-465F-805A-B941D88E27E0Q36398769-4E28FDBD-1C0B-495C-9B32-D774FF9BE379Q36431024-8B2E3EA6-512D-4205-921C-5BBA1CFD10F5Q37067033-03E79630-2B32-491C-8047-0303ABB548F6Q37103894-F7A495DC-80B9-4BCA-AAAF-CC2CF9648EB5Q37148793-CDB37389-3F7B-420C-B033-4FDDD7014C19Q37357538-07D62CBF-4FCA-4B7A-A664-BC3824BA140AQ37431946-9BF91FF6-A13A-4A31-AFA6-5D6D872BEB32Q37719981-BC594525-0976-4214-BE5A-FD0F1A67A370Q38010707-1A3E1C50-E0BB-4186-856D-58A9A1DAD4E4Q38041099-AA8DE417-675B-4E8C-B929-B6E71949BC44Q38138901-31AB5EC5-8A84-415E-99D0-50AC90775D5CQ38584979-2905CA2B-2092-420E-AD1C-404280C34B3CQ38756468-2F346AFB-BC63-486A-8BBE-D0AA6EB11C13Q38961442-7B29AC3E-56F7-42F9-83EC-F37624599C9AQ39108144-A714811F-069F-4839-97D6-5226FF2A2659Q40238354-88D9162C-24CB-43EA-AAE2-745C5E529FFDQ41542550-249BB790-2694-4563-ADB7-6092C08E9F85Q42074207-C7E91C0F-7A80-4E07-AEC6-4DBF6C48EBA3Q42100048-EF9CBBD0-9C7B-4C79-9CC9-A02A7359FC37Q42175341-AA463ED6-A7A6-4F79-9A51-2F09C13E1E3AQ42494705-CD99697F-E4EA-4A56-BAB8-AB3B16129C72Q43529147-B5F55BB9-9A81-453E-8753-8C0DD55E62D7Q52348457-4CF41D61-F6D1-49C0-85BB-EE6D9E843B2FQ53113182-0F5E2D58-ABA8-4DF4-917E-149511938FC1Q55285607-8FF41FFF-3C3B-4FB4-8302-325CC102F242Q57476217-B37BC4BA-7089-414B-98F4-04465BAD3B59
P2860
TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@ast
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@en
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@nl
type
label
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@ast
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@en
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@nl
prefLabel
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@ast
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@en
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@nl
P2093
P356
P1476
TIM-3 is expressed in melanoma ...... GF-beta stimulated mast cells.
@en
P2093
Barbara Kohalmi
Gergely Tolgyesi
Judit Jeager
Peter Pocza
Zoltan Papp
Zoltan Wiener
P2888
P304
P356
10.1038/SJ.JID.5700616
P407
P50
P577
2006-11-09T00:00:00Z
P5875
P6179
1026393391